Assessment of aspirin response in patients undergoing neuroendovascular treatments: A comparison of five platelet function tests across two platforms
Year: 2026
Type: article
Study design: Observational Study
Abstract: Aspirin is widely used for periprocedural antiplatelet therapy in neuroendovascular procedures; however, variability in patient response poses clinical challenges. This study aimed to assess five platelet function tests on two different platforms: light transmission aggregometry (LTA) using the CN-6000 device and the VerifyNow system, which were utilized to assess patients undergoing neuroendovascular procedures. A total of 124 patients who underwent elective neuroendovascular procedures and received perioperative aspirin-based antiplatelet therapy between September 2020 and December 2023 were retrospectively reviewed. Platelet function was assessed at three time points: before surgery, 1-3 days after surgery, and 1 month following the procedure. The assessments included maximum aggregation (MA) induced by 1 mM arachidonic acid (AA), 10 μM ADP, and 1 μg/mL collagen, as well as collagen-induced platelet aggregation level (CPAL) and aspirin reaction units (ARU). Significant perioperative changes were observed only with 1 mM AA MA, which increased immediately after surgery (p < 0.001) and decreased at 1 month (p = 0.013), while other tests showed no significant differences. Correlation analysis revealed the strongest association between 1 mM AA MA and 1 μg/mL collagen MA (r = 0.65), followed by CPAL (r = 0.62). ARU correlated modestly with LTA-based measures (r ≤ 0.34). Receiver operating characteristic analysis identified CPAL >6.0 and collagen MA > 43.2% as equivalent to AA MA > 20%. In this cohort, perioperative changes were detected by 1 mM AA MA but not by the other platelet function tests, and correlations between VerifyNow ARU and LTA-based measurements were modest. However, the clinical significance of these differences remains to be established. Automated LTA using CN-6000 may offer a practical option for aspirin monitoring in patients undergoing neuroendovascular procedures. Further prospective studies are warranted to validate its clinical utility.
Source: PLoS ONE
Institutions: Sysmex (Japan), Gifu University, Gifu University Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funder: Sysmex Corporation
OpenAlex ID: W7236722764
